He, Leicheng. “SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits”. Highlights in Science, Engineering and Technology 74 (December 29, 2023): 1717–1722. Accessed June 8, 2026. https://drpress.org/ojs/index.php/HSET/article/view/16046.